Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 1/20 | 0.43 |
| ▸ | CES2 | O00748 | 1/20 | 0.42 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.34 |
| ▸ | LSS | P48449 | 2/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | PDE7A | Q13946 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26730980 | 0.77 | ACHE (0.49) | ACHEALDH1A1PDE7A | |
| SCHEMBL27045475 | 0.76 | ACHE (0.39) | ACHEALDH1A1 | |
| SCHEMBL24739058 | 0.76 | ADH1A (0.38) | ACHEALDH1A1L3MBTL1MEN1KMT2A | |
| SCHEMBL13612632 | 0.74 | ACHE (0.40) | ACHEALDH1A1 | |
| SCHEMBL20254246 | 0.74 | ALDH1A1 (0.38) | ACHEALDH1A1 | |
| SCHEMBL14450469 | 0.73 | CES2 (0.48) | CES2OPRK1ALDH1A1TDP1NPSR1 | |
| SCHEMBL24437849 | 0.73 | ADH1A (0.43) | ACHEALDH1A1MEN1KMT2A | |
| SCHEMBL7805428 | 0.71 | ALDH1A1 (0.42) | ALDH1A1TDP1L3MBTL1MEN1KMT2A | |
| SCHEMBL18878200 | 0.71 | ACHE (0.37) | ACHEALDH1A1PDE7A | |
| SCHEMBL65088 | 0.71 | CES2 (0.50) | CES2OPRK1ALDH1A1TDP1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022253101-A1 | PYRIDAZINONE COMPOUND AS PARP7 INHIBITOR | 上海优理惠生医药有限公司 | 2022-12-08 | — | — | WO | disclosed |